Having a skin lesion biopsied for nonmelanoma skin cancer is a quick office procedure, but it can take days to get the pathology report. A novel 2-photon fluorescence microscopy imaging system developed by University of Rochester researchers could shorten the wait to as little as 2 minutes. This would enable a surgeon to immediately determine whether the lesion is cancerous
Understanding the link between diabetes and cancer has been the focus of intense research for many years. A new study suggests that people with elevated levels of the plasma protein prostasin may be at higher risk of developing diabetes. The findings also indicate that individuals with elevated levels of both blood sugar and prostasin appear at a significantly greater risk
Researchers have developed a two-step approach using whole exome sequencing to predict whether cancer patients will respond to immunotherapy. Immunotherapies, such as immune checkpoint inhibitors, have transformed the treatment of advanced cancers. However, these therapies have not worked for everyone. To better predict who will benefit from immunotherapy, scientists have developed various biomarkers that help anticipate immunotherapy treatment response. Several
Breast cancer is the second most common cancer among women in the United States. Studies are providing a better understanding of the underlying biology of breast cancer and identifying opportunities for treatments. Researchers at Georgetown Lombardi Comprehensive Cancer Center conducted one such investigation. They analyzed expanded epithelial cells from women with breast cancer who had chemotherapy before their surgery and found
Colorectal cancer is the third most common cancer worldwide. An estimated 106,180 new cases of colon cancer and 44,850 new cases of rectal cancer will be diagnosed in the US in 2022. Many of these patients will develop unresectable colorectal cancer liver metastases (CRLMs). A March 2022 study is the first in North America to demonstrate that a living-donor liver